{
    "organizations": [],
    "uuid": "94a18d7fa6ab55a37cfee45263fec72d55e2dcf5",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-zomedica-signs-agreement-with-sera/brief-zomedica-signs-agreement-with-seraph-biosciences-for-innovative-veterinary-point-of-care-diagnostic-idUSFWN1SH0QD",
    "ord_in_thread": 0,
    "title": "BRIEF-Zomedica Signs Agreement With Seraph Biosciences For Innovative Veterinary Point-Of-Care Diagnostic",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 10 (Reuters) - Zomedica Pharmaceuticals Corp:\n* ZOMEDICA SIGNS AGREEMENT WITH SERAPH BIOSCIENCES FOR INNOVATIVE VETERINARY POINT-OF-CARE DIAGNOSTIC\n* ZOMEDICA PHARMACEUTICALS - ENTERED INTO A DEVELOPMENT, COMMERCIALIZATION, EXCLUSIVE DISTRIBUTION DEAL WITH SERAPH BIOSCIENCES\n* ZOMEDICA PHARMACEUTICALS CORP - DEAL WITH SERAPH COVERS DEVELOPMENT & VALIDATION OF ZM-020 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-10T18:58:00.000+03:00",
    "crawled": "2018-05-11T12:32:44.044+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "zomedica",
        "pharmaceutical",
        "corp",
        "zomedica",
        "sign",
        "agreement",
        "seraph",
        "bioscience",
        "innovative",
        "veterinary",
        "diagnostic",
        "zomedica",
        "pharmaceutical",
        "entered",
        "development",
        "commercialization",
        "exclusive",
        "distribution",
        "deal",
        "seraph",
        "bioscience",
        "zomedica",
        "pharmaceutical",
        "corp",
        "deal",
        "seraph",
        "cover",
        "development",
        "validation",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}